Previous research has shown that mutations of BCKDH, which catalyzes the irreversible and rate-limiting step of BCAAs catabolism, lead to abnormal accumulation of BCAAs and their metabolites, resulting in maple syrup urine disease. Here, PPM1K is linked to maple syrup urine disease.